NutriSelect Files Provisional Patent for Precision Supplement Intelligence™ Platform

June 20, 2025 11:00 PM AEST | By EIN Presswire

Google News:

Recent News

Fed Daly eyes fall for possible policy shift

Fifth Third Announces Three-Year, $20M Investment in North Nashville

Inogen Alliance Associate Awards: Environment Analyst Sustainability D...

New Zealand Construction Report 2025: Output to Contract by 1% Due to...

CLEARWATER, FL, UNITED STATES, June 20, 2025 /EINPresswire.com/ -- NutriSelect.ai, Inc., a science-driven health tech startup redefining personalized wellness, announced today that it has officially filed a provisional patent application with the United States Patent and Trademark Office (USPTO) to protect its proprietary Precision Supplement Intelligence™ framework.

This innovative system powers NutriSelect’s core product, an AI-powered mobile platform that delivers personalized supplement recommendations based on scientific evidence, clinical validation, and real-time health data. The patent application outlines NutriSelect’s proprietary scientific rating algorithm—known as the NScore™—that evaluates supplement products across multiple criteria including quality of evidence, dosage accuracy, regulatory standards, and clinical reproducibility.

“This filing represents a major milestone for NutriSelect,” said Dr. Bill Clark, PhD Founder & CEO. “Our mission is to eliminate guesswork and misinformation in the $68 billion U.S. supplement industry by giving consumers access to objective, science-backed insights tailored to their health goals. The NScore is core to that promise.”

“Consumers around the world face the same core challenge: figuring out which supplement to take,” said Dr. Bill Clark, an expert in international regulations and supplement launches. “While our initial focus is on building a robust platform for the massive U.S. market, we’ve already received strong interest from Europe and Asia. Science is science—regardless of geography and regulation—and our vision is to scale NutriSelect globally to support informed, evidence-based wellness everywhere.”

The announcement follows recent momentum, including signed Letters of Intent (LOIs) with leading clinical research organizations and an international health tech company preparing to enter the U.S. market.

About NutriSelect.ai, Inc.

Founded by Dr. Bill Clark, PhD — chemist, inventor, and Top 100 Innovators & Entrepreneurs designee — NutriSelect.ai is a patent-pending, AI-powered platform delivering Precision Supplement Intelligence™. The system provides personalized, science-backed supplement recommendations by evaluating products through clinical evidence, biomarker alignment, and transparency standards. With integrated real-time health progress tracking and actionable wellness insights, NutriSelect empowers consumers to take control of their health, make confident choices, and optimize their long-term well-being.

NutriSelect is currently raising its pre-seed round and has been featured in NutraIngredients-USA, The Top 100 Innovators & Entrepreneurs for 2025, Medium, and the Founder Sense podcast.

Dr. Bill Clark, PhD
NutriSelect.ai, Inc.
[email protected]
Visit us on social media:
LinkedIn
Instagram
Facebook
YouTube
X
Other

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.